Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.

Shen WY, Lai CM, Lai YK, Zhang D, Zaknich T, Sutanto EN, Constable IJ, Rakoczy PE.

J Gene Med. 2003 Jul;5(7):576-87.

PMID:
12825197
2.

Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.

Rolling F.

Gene Ther. 2004 Oct;11 Suppl 1:S26-32. Review.

PMID:
15454954
3.

Adeno-associated viral vectors for gene transfer and gene therapy.

B├╝eler H.

Biol Chem. 1999 Jun;380(6):613-22. Review.

PMID:
10430026
4.

rAAV vector-mediated gene therapy for experimental ischemic stroke.

Li ZJ, Wang RZ.

Neurol India. 2008 Apr-Jun;56(2):116-21. Review.

5.

[Progress in somatic gene therapy of retinal degeneration in the animal model].

Schlichtenbrede FC, Sarra GM, Ali RR, Wiedemann P, Reichel MB.

Ophthalmologe. 2002 Apr;99(4):259-65. Review. German.

PMID:
12058500
6.

Recombinant AAV-mediated gene delivery to the central nervous system.

Tenenbaum L, Chtarto A, Lehtonen E, Velu T, Brotchi J, Levivier M.

J Gene Med. 2004 Feb;6 Suppl 1:S212-22. Review.

PMID:
14978764
8.

Iris pigment epithelial cell transplantation for degenerative retinal diseases.

Abe T, Yoshida M, Yoshioka Y, Wakusawa R, Tokita-Ishikawa Y, Seto H, Tamai M, Nishida K.

Prog Retin Eye Res. 2007 May;26(3):302-21. Epub 2007 Jan 17. Review.

PMID:
17324604
9.
10.

Gene transfer by adeno-associated virus vectors into the central nervous system.

Xiao X, Li J, McCown TJ, Samulski RJ.

Exp Neurol. 1997 Mar;144(1):113-24. Review.

PMID:
9126160
11.

Gene therapy for retinal and choroidal diseases.

Campochiaro PA.

Expert Opin Biol Ther. 2002 Jun;2(5):537-44. Review.

PMID:
12079489
12.

Gene therapy: recombinant adeno-associated virus vectors.

Smith-Arica JR, Bartlett JS.

Curr Cardiol Rep. 2001 Jan;3(1):43-9. Review.

PMID:
11139798
13.

Gene therapy for ocular angiogenesis.

Bainbridge JW, Mistry AR, Thrasher AJ, Ali RR.

Clin Sci (Lond). 2003 Jun;104(6):561-75. Review.

PMID:
12570869
14.

Adeno-associated virus expression systems for gene transfer.

Rabinowitz JE, Samulski J.

Curr Opin Biotechnol. 1998 Oct;9(5):470-5. Review.

PMID:
9821274
15.

Adeno-associated virus-mediated gene delivery.

Snyder RO.

J Gene Med. 1999 May-Jun;1(3):166-75. Review.

PMID:
10738565
16.

Defective viral vectors as agents for gene transfer in the nervous system.

Kaplitt MG, Makimura H.

J Neurosci Methods. 1997 Jan;71(1):125-32. Review.

PMID:
9125381
17.

Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to reality.

Muramatsu S, Wang L, Ikeguchi K, Fujimoto K, Nakano I, Ozawa K.

J Neurol. 2002 Sep;249 Suppl 2:II36-40. Review.

PMID:
12375062
18.

Production of recombinant adeno-associated virus.

Gao GP, Wilson JM, Wivel NA.

Adv Virus Res. 2000;55:529-43. Review.

PMID:
11050955
19.

Production of clinical-grade recombinant adeno-associated virus vectors.

Snyder RO, Flotte TR.

Curr Opin Biotechnol. 2002 Oct;13(5):418-23. Review.

PMID:
12459331
20.

Gene delivery to the eye using adeno-associated viral vectors.

Martin KR, Klein RL, Quigley HA.

Methods. 2002 Oct;28(2):267-75. Review.

PMID:
12413426
Items per page

Supplemental Content

Write to the Help Desk